Novel HMG-CoA reductase inhibitors
US4866090A · kind A · utility
20Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 1988 |
| Grant date | Sep 12, 1989 |
| Priority date | — |
| Expiry date | Jan 7, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II): ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.